Insights from Multimodal Preclinical Imaging in Immunocompetent Nude Mice by Tondera, Christoph et al.






2016; 6(12): 2114-2128. doi: 10.7150/thno.16614 
Research Paper 
Gelatin-based Hydrogel Degradation and Tissue 
Interaction in vivo: Insights from Multimodal Preclinical 
Imaging in Immunocompetent Nude Mice 
Christoph Tondera1,2, Sandra Hauser1, Anne Krüger-Genge3, Friedrich Jung3,4, Axel T. Neffe3,4, Andreas 
Lendlein3,4, Robert Klopfleisch5, Jörg Steinbach2,6, Christin Neuber1, Jens Pietzsch1,2  
1. Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Department of Radiopharmaceutical and Chemical Biology, 
Dresden, Germany; 
2. Technische Universität Dresden, Department of Chemistry and Food Chemistry, Dresden, Germany; 
3. Institute of Biomaterial Science and Berlin-Brandenburg Centre for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, Teltow, Germany; 
4. Helmholtz Virtual Institute “Multifunctional Biomaterials for Medicine”, Teltow and Berlin; 
5. Freie Universität Berlin, Institute of Veterinary Pathology, Berlin, Germany; 
6. Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.  
 Corresponding author: Phone: +49 351 260 2622; Fax: +49 351 260 12622; j.pietzsch@hzdr.de (J. Pietzsch). 
© Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See 
http://ivyspring.com/terms for terms and conditions. 
Received: 2016.06.27; Accepted: 2016.08.05; Published: 2016.09.12 
Abstract 
Hydrogels based on gelatin have evolved as promising multifunctional biomaterials. Gelatin is 
crosslinked with lysine diisocyanate ethyl ester (LDI) and the molar ratio of gelatin and LDI in the 
starting material mixture determines elastic properties of the resulting hydrogel. In order to 
investigate the clinical potential of these biopolymers, hydrogels with different ratios of gelatin and 
diisocyanate (3-fold (G10_LNCO3) and 8-fold (G10_LNCO8) molar excess of isocyanate groups) 
were subcutaneously implanted in mice (uni- or bilateral implantation). Degradation and 
biomaterial-tissue-interaction were investigated in vivo (MRI, optical imaging, PET) and ex vivo 
(autoradiography, histology, serum analysis). Multimodal imaging revealed that the number of 
covalent net points correlates well with degradation time, which allows for targeted modification 
of hydrogels based on properties of the tissue to be replaced. Importantly, the degradation time 
was also dependent on the number of implants per animal. Despite local mechanisms of tissue 
remodeling no adverse tissue responses could be observed neither locally nor systemically. Finally, 
this preclinical investigation in immunocompetent mice clearly demonstrated a complete 
restoration of the original healthy tissue. 
Key words: Autoradiography ex vivo, Biomaterials, Computed tomography, Magnetic resonance imaging,  
Optical imaging,  Positron emission tomography. 
Introduction 
In recent years, hydrogel-based biomaterials 
have evolved as highly versatile and promising tools 
for clinical [1] and research [2] applications. Different 
hydrogels are produced depending on the specific 
need, such as soft tissue replacement, organ patches, 
or drug delivery systems. Hydrogels with different 
physical properties can also be designed and 
implanted in non-self-healing critical size defects, 
temporarily replacing the extracellular matrix (ECM), 
and assisting the healing process for example in bony 
structures [3]. The material of choice should be 
degraded in rates suitable for the envisioned 
application, allowing optimal ingrowth of cells and 
supporting the wound healing process. Ideally, 
physical properties such as Young’s and compression 
moduli of the material match those of the tissue to be 
replaced and help to guide cells to promote tissue 








properties of polymers at the start of their application 
as well as during their degradation may be reached by 
the formation of polymer networks. For this purpose, 
biopolymers derived from ECM are attractive 
materials, as they are degradable, offer sites for cell 
adhesion, and are generally highly biocompatible [4]. 
Current clinical applications for soft tissue 
replacement focus mainly on the use of collagen or 
differentially cross-linked collagen [5]. However, 
immunogenic responses to collagen-based implants 
have been reported [6]. In addition, cross-linking 
agents needed for network formation may show toxic 
side effects [7] during material degradation processes 
[8], which could induce adverse tissue reactions, such 
as strong inflammatory and immunogenic responses, 
thereby adversely affecting the healing process and 
successful tissue restoration [9,10]. 
Previous research has shown that gelatin, which 
is the partial thermally and chemically degraded 
product of collagen, possesses lower immunogenicity 
than collagen [11], and can be stabilized through the 
introduction of covalent net points [12]. Gelatin as 
highly biocompatible, biodegradable, low 
immunogenic, and low-cost material is therefore 
highly attractive for future clinical applications e.g. in 
soft tissue replacement strategies [13]. 
The use of gelatin-based hydrogels stabilized 
through reaction with lysine diisocyanate ethyl ester 
(LDI) [14] has already yielded promising in vitro 
results in the interaction with mesenchymal stem cells 
[15] and arterial endothelial cells [16]. First results 
from a pilot animal experiment using an 
immunocompetent nude mouse (SKH1) model 
further revealed a high degree of biocompatibility 
together with a specific degradation response of the 
cross-linked gelatin over 35 days. This has been 
demonstrated by histological (Masson Goldner 
staining) and immunohistochemical (cyclooxygenase- 
2 staining) examinations of sections from explants of 
hydrogels with surrounding tissue ex vivo [16]. For a 
better understanding of intra-individual physiological 
processes as well as potential long lasting and late 
effects, it is necessary to employ in vivo imaging 
techniques depicting the degradation of the implant, 
biomaterial-tissue-interactions, and systemic reactions 
in a quantitative manner, and to correlate these 
findings with ex vivo techniques showing local cellular 
behavior. Thereby, multimodal and multiscale 
techniques contribute to a better understanding of the 
biological response to the hydrogels and will provide 
selection criteria for potential therapeutic 
applications. 
This comprehensive small animal multimodal 
and multiscale imaging study in SKH1 mice 
conducted in vivo and ex vivo aimed at detailed 
elucidation of hydrogel degradation, tissue response, 
integration, and systemic response at different time 
points (1, 7, 14, 21, 35 days) up to 84 days post 
subcutaneous implantation of two hydrogels with 
different numbers of covalent and physical net points.  
Methods 
Hydrogel preparation. Sterile, dried hydrogel 
implants of gelatin-based networks G10_LNCO3 and 
G10_LNCO8 were synthesized as described before 
[14,15], and quality control was achieved by 
controlling the rheological and swelling behavior of 
the films as well as their FT-IR spectra. Briefly, 
hydrogels were synthesized by reacting a 10% (w/v) 
aqueous gelatin solution (from porcine skin, 200 
bloom, type A, low endotoxin content, GELITA) in the 
presence of 1% (w/v) poly(ethylene glycol)- 
block-poly(propylene glycol)-block-poly(ethylene 
glycol) (Pluronic® F-108, SigmaAldrich) with 
different amounts of ethyl lysine diisocyanate ethyl 
ester (LDI; 3-fold and 8-fold molar excess of NCO 
groups compared to NH2 groups of the gelatin). Two 
gelatin-based hydrogels with different degree of 
crosslinking, G10_LNCO3 and G10_LNCO8, were 
obtained. 
Hydrogel implantation. Animal experiments 
were performed in accordance with the guidelines of 
the German Regulations for Animal Welfare. The 
protocol was approved by the local Ethical Committee 
for Animal Experiments (reference number 
24-9168.11-4/2013-1). The implantation procedure 
was done as described previously [16]. Briefly, female 
immunocompetent SKH1-Elite mice were purchased 
from Charles River. SKH1 mice (age 8-15 weeks, 
weight 22-30 g) were implanted subcutaneously (s.c.) 
at the lower back with one hydrogel piece of 
G10_LNCO3 (left side) or G10_LNCO8 (right side) or 
with both G10_LNCO3 and G10_LNCO8 at the left 
and right side, respectively. Mice were anesthetized 
using 8% (v/v) desfluran (Baxter). A small incision (< 
5 mm length) was made on the dorsal area. 
Subcutaneous skin pockets were formed posterior to 
incision using surgical scissors. The hydrogel pieces 
(1-2 × 3 × 10 mm size, 1 h swollen in PBS, sterile, 
endotoxin free) were implanted and the wound was 
closed using spray dressing. Sham-operated animals 
followed the same procedure except for the actual 
hydrogel implantation. All animals received the 
analgesic Rimadyl (5 mg/kg) as single injection. 
Volume determination measurements. 
Hydrogel implant volume was determined in vivo 
using dedicated 7 T small animal magnetic resonance 
imaging (MRI, Bruker) with a T2-weighted measuring 
(TRARE) sequence. Relaxation time was 38 ms. 
Resolution was 156 µm in x-y-direction and as 




determined by the slice thickness 800 µm in 
z-direction. For quantification of the hydrogel volume 
the software ROVER (ABX GmbH) was used. To 
distinguish water (water-1H) from fatty acid (fat/fatty 
acid/lipid-1H) chemical environment protons spectral 
MRI analysis was performed as published elsewhere 
[17]. Of importance, no MRI contrast agents were 
used. To verify the MRI volume quantification a 
computed tomography-based (NanoScan CT, Mediso) 
ex vivo method was used. For this purpose, hydrogels 
together with surrounding tissue were surgically 
removed at different time points representing 
different material sizes for both hydrogels. The tissue 
samples were fixed for 24 h in 4% (w/v) 
paraformaldehyde (PFA) at room temperature, 
incubated for 3 days in 20% (w/v) sucrose solution at 
4°C, and afterwards stored at -65°C. For ex vivo CT 
measurements the tissue samples of a subgroup of 
double-implanted animals (n=4) were dehydrated by 
incubation in a graded series of 30%, 50%, and 70% 
(v/v) ethanol for 24 h each concentration. Staining 
was performed in 0.3% (w/v) of phosphotungstic acid 
(PTA) in 70% (v/v) ethanol for 49 days. For 
visualization using CT, samples were measured with 
a resolution of 42 µm in xyz. The volume was 
quantified using ROVER (ABX GmbH). 
In vivo luminescence and fluorescence 
imaging. For luminescence and fluorescence 
measurements the small animal optical imaging 
device in vivo Xtreme (Bruker) was used. The detection 
of reactive oxygen species was performed using the 
luminescent probe L-012 (Wako Chemicals). Animals 
were injected intraperitoneally (i.p.) with 1.5 mg/100 
µl L-012 in 0.9% (w/v) sodium chloride (60 mg/kg) 
and luminescence was measured 30 min after 
injection using 4 × 4 binning and 5 min exposure time. 
COX-2 was visualized using the fluorescent probe 
XenoLight RediJect (Perkin Elmer, 570/600 nm). 100 
µl of the solution were injected i.p. and fluorescence 
was measured 3 h post injection. To induce an 
inflammatory response, which served as positive 
control for both L-012 and XenoLight RediJect, 
12-O-Tetradecanoylphorbol-13-acetate (TPA) was 
used [18,19]. Animals were injected with 100 µl of a 
100 µM TPA solution behind the ear and in the lower 
dorsal area on the right side on day 1 and day 2. On 
day 3 animals were again injected with 50 µl of the 
same TPA solution. In parallel, the same amount of 
0.9% (w/v) sodium chloride solution was injected on 
the left side of the animals as a negative control. MMP 
activity was determined using MMP-Sense 680 
(Perkin Elmer, 650/700 nm). 24 h after intravenous 
(i.v.) injection of 100 µl MMP-Sense 680, fluorescence 
was assessed using optical imaging. 
Exposure time for fluorescence images was 1 s. 
As reference, a channel with no specific fluorescence 
GFP (480/535 nm) was chosen and an image with an 
exposure time of 4 s was acquired.  
For the acquisition and quantification of images 
Bruker Molecular Imaging software version 7.2 was 
used. For luminescence images, net luminescence 
intensity was determined. To minimize quantification 
of unspecific auto-fluorescence, fluorescence images 
of MMP activity measurements were first divided by 
the reference channel. Subsequently, net fluorescence 
intensity was quantified. 
PET imaging. Dynamic small animal positron 
emission tomography (PET) after i.v. injection of 
[18F]fluorodeoxyglucose ([18F]FDG) was performed in 
mice implanted with either G10_LNCO3 or 
G10_LNCO8 and mice implanted with both 
G10_LNCO3 and G10_LNCO8 on day 14, 21, and 35 
after implantation. PET acquisition was performed 
using NanoScan PET/CT scanner (Mediso) and the 
protocol given in detail elsewhere [20]. In brief, PET 
acquisition was started 20 s before infusion of 
[18F]FDG (10 MBq in 200 µl 0.9% NaCl) through a 
needle catheter into a lateral tail vein. Emission data 
were collected continuously for 60 min. The 3D list 
mode data were sorted into sinograms with 32 frames 
(15 × 10 s, 5 × 30 s, 5 × 60 s, 4 × 300 s, 3 × 600 s). The 
data were decay, scatter, and attenuation (X-ray) 
corrected. The frames were reconstructed by 
maximum a posteriori (MAP) method with 4 
iterations and 6 subsets. Image volume data were 
converted to Siemens ECAT7 format, co-registered to 
MRI data, and analyzed by ROVER software (ABX 
GmbH). Based on MRI data, masks were determined 
around G10_LNCO3 or G10_LNCO8 and 
three-dimensional regions of interest (ROI) were 
defined by thresholding PET data within these masks. 
In cases where thresholding of PET data was 
impossible due to insufficient activity or close 
proximity to a high [18F]FDG accumulating organ 
such as the kidney, thresholding was performed on 
MRI data and the ROI was translated to PET data. 
Standardized uptake values (SUVs) were calculated 
over the ROI as a ratio of activity concentration at 
time t and injected dose at time of injection (t0) 
divided by body weight. Following PET scanning (60 
min p.i.) at day 35, mice were sacrificed and subjected 
to ex vivo whole-body autoradiography. 
Serum sample preparation and analysis. At 
selected time points, whole blood samples were 
collected by heart puncture of 4 anesthetized mice for 
each group and allowed to clot for 30 min at room 
temperature. Samples were centrifuged at 2,000 × g 
for 15 min at 4°C. The supernatant was transferred 
into a fresh tube and snap frozen in liquid nitrogen 
immediately. Serum was stored at −65°C. 




Cytokine concentrations of serum samples were 
quantified using Bioplex Pro™ Mouse Cytokine 
26-plex Assay from Bio-Rad and MMP concentrations 
were quantified using MILLIPLEX® Map (Mouse 
MMP Magnetic Bead Panel 1 and 2, Luminex®). 
Histological analysis. For histological analysis 3 
animals per group were sacrificed at the selected time 
points. The hydrogels were surgically removed 
including the surrounding tissue. The tissues were 
fixed in 4% (w/v) PFA for 24 h at room temperature 
and incubated for 3 days in 20% (w/v) sucrose in 
phosphate buffered saline (PBS) at 4°C solution. 
Tissue samples were snap frozen and stored at -65°C. 
For cryosectioning samples were cut through the 
middle of the remaining hydrogel piece. Samples 
were embedded in 7.5% (w/v) gelatin solution with 
20% (w/v) sucrose in PBS, frozen, and cut at 10 µm 
thickness using a cryostat at -30°C. Histological 
samples were stained by hematoxylin & eosin (H&E) 
using standard protocols. Specific tissue response was 
visualized using immunohistochemical staining for 
different cell markers, which are summarized in Table 
1.  
Except for VEGFR-2 staining, where a 
fluorescent secondary antibody (Alexa-Fluor 647) was 
used, biotinylated secondary antibodies were used. 
After incubation with ExtrAvidin peroxidase 
(Sigma-Aldrich), staining was visualized using AEC 
substrate kit (BD Biosciences). Sections were 
counterstained using Mayer’s hematoxylin. 
Fluorescence staining of VEGFR-2 sections was 
counterstained with Hoechst 33258 (Life 
Technologies™). Images were acquired using 
AxioImager.A1 and the appropriate software package 
AxioVision (Carl Zeiss). Fluorescent images were 
acquired using a laser scanning confocal microscope 
(IX83, Olympus) and the appropriate software 
FluoView (Olympus). 
Quantification of immunohistochemical staining 
was performed for sections of three different animals 
per time point using ImageJ/FIJI [30]. To this end, the 
color threshold plugin was used. RGB values were set 
for cell nuclei and for immunohistochemically 
positively stained areas. Subsequently, the plugin 
“analyze particles” was applied. The positively 
stained area was divided by area of cell nuclei for 
AEC staining or by number of cell nuclei for 
fluorescent staining. 
To measure capsule thickness of the implanted 
hydrogels van Gieson's staining was performed using 
standard protocols. Cell nuclei were stained using 
Weigert’s iron hematoxylin solution. Collagen was 
stained using Van-Gieson-mixture consisting of 
saturated picric acid and 1% (w/v) thiazine red. For 
the measurement of capsule thickness AxioVision 
(Carl Zeiss) software was used. Capsule thickness was 
measured for sections of three different animals per 
time point. For each section 5 points on each 
capsule-side (the skin- and muscle-side) around the 
implant were measured. 
For pathohistological investigation organs 
(inguinal lymph nodes, kidneys, liver, and spleen) 
were surgically removed and fixed in 4% (w/v) PFA 
for 24 h at room temperature. The organs were 
washed for 1 h in PBS to remove the PFA and stored 
in PBS with 0.1% (w/v) sodium azide until paraffin 
blocks were prepared. All organs were cut into 1 µm 
thick sections and stained by H&E for subsequent 
pathological examination. 
 
Table 1: Antibodies used for immunohistochemical staining. 
Antibody Catalog no. Dilution Species Antigen retrieval Cell or tissue type 
Primary antibody  
CD31 (abcam) ab28364 1:75 Rabbit Citrate buffer Blood vessels [21] 
CD34 (abcam) ab81289 1:200 Rabbit Citrate buffer Progenitor cells [22,23] 
CD68 (AbD Serotec) MCA-1957 1:100 Rat - Macrophages [24] 
CD206 (abcam) ab64693 1:100 Rabbit Citrate buffer M2-macrophages [25] 
Involucrin (abcam) ab28057 1:1500 Rabbit Citrate buffer Keratinocytes [26] 
Ki67 (abcam) ab15580 1:200 Rabbit Citrate buffer Proliferatory cells [27] 
Lrig-1 (abcam) ab36707 1:200 Rabbit Citrate buffer Fibroblast stem cells [28] 
S100A4 (Thermo Scientific) RB-9411 1:100 Rabbit Citrate buffer Fibroblasts [29] 
VEGFR-2 (abcam) ab39256 1:100 Rabbit Citrate buffer Newly formed blood vessels [21] 
Isotype-control  
Rabbit polyclonal IgG (abcam) ab27478 Concentration equal to 
primary antibody 
Rabbit Equal to primary 
antibody 
 




Equal to primary 
antibody 
 
Secondary antibody  
Goat anti-rabbit (Dianova) 111-065-003 1:200 Goat   
Rabbit anti-rat (Dianova) 312-066-045 1:100 Rabbit   
Goat anti-rabbit Alexa-Fluor 647 (Life 
Technologies™) 
A21245 1:200 Goat   




Statistical analysis. Statistical significance of 
measured degradation volumes, in vivo MMP activity, 
serum cytokine levels and serum MMP levels was 
calculated using two-way ANOVA followed by a 
Bonferroni post hoc test using Prism 6 (GraphPad 
Software). Statistical significance was assumed for p < 
0.1 in case of histological stainings and p < 0.01, p < 
0.05 for all other statistical analyses. Descriptive data 
were expressed as means and standard deviations. 
For correlation between datasets Pearson correlation 
coefficient was calculated.  
Results 
Quantification of hydrogel degradation in vivo: 
methodological considerations 
To determine the volume of implanted 
gelatin-based hydrogels, magnetic resonance imaging 
(MRI) with a specifically designed T2 weighted 
measuring sequence was performed. Both 
G10_LNCO3 and G10_LNCO8, two gelatin-based 
hydrogels with different crosslinking levels and 
therefore different surface structures, physical and 
mechanical properties [14,15] (Fig. 1a, Table 2), could 
be clearly visualized by MRI (Fig. 1b).  
 
 
Figure 1. Hydrogel implantation and visualization. (a) Synthesis scheme of gelatin-based hydrogels G10_LNCO. Gelatin was reacted with 3- or 8-fold excess of L-lysine 
diisocyanate ethyl ester (LDI) related to amine-groups in gelatin for G10_LNCO3 and G10_LNCO8 (upper left panel). Confocal microscopy images reveal different surface 
structures of the different hydrogels (upper right panel). Implantation workflow is shown in the lower panel. First mice skin is disinfected, second incision and skin pocket is 
formed, third pre-swollen hydrogel is implanted, fourth incision is closed by the use of spray-plaster. (b) Representative axial MRI images on day 1 and day 35 after implantation. 
After drawing a volume of interest around the material (red sphere) and applying a threshold (middle panel) the volume of the hydrogels could be calculated. Hematoxylin & Eosin 
(H&E) staining confirmed difference in degradation of G10_LNCO3 and G10_LNCO8 35 days after implantation (right panel).  




Table 2: Physical and mechanical properties of G10_LNCO3 and 
G10_LNCO8 
 G10_LNCO3 G10_LNCO8 
Young’s modulus 13 ± 3 kPa 55 ± 11 kPa 
Elongation at break 43 ± 25% 30 ± 11% 
Tensile strength 7 ± 3 kPa 19 ± 11 kPa 
 
Ex vivo cryosections revealed similar sizes for the 
hydrogels compared to the sizes at the MRI images at 
the different time points (Fig. 1b). To determine 
whether the volume measured by MRI represents the 
actual volume of the hydrogel, spectral MRI analysis 
was performed to distinguish free water molecules 
from non-covalently bound water and fatty acid 
chemical environment protons [17] (Fig. S1a). Spectra 
of both materials showed only one prominent peak, 
assigned to the free water signal. Therefore, protons 
measured within the hydrogel are in chemical 
environment of free water, which is in accordance 
with the situation in a swollen hydrogel [31,32]. 
Computed tomography (CT) as an additional imaging 
method was applied to verify the MRI volume 
quantification (Fig. S1b). Due to similar densities of 
the gelatin-based hydrogels compared to the 
surrounding tissue the material could not be 
visualized and, therefore, not be quantified directly 
using small animal CT measurements in vivo. 
Consequently, volume of implanted hydrogels was 
initially quantified at different time points after 
implantation using MRI. Immediately after 
performing MRI measurements, a subgroup of 
double-implanted animals (n=4) was sacrificed. The 
implanted material as well as the surrounding tissue 
was surgically removed and explants were further 
processed for phosphotungstic acid (PTA) staining. 
PTA binds to fibrin, collagen, and other proteins that 
are ubiquitously present in connective tissues 
throughout all organs, allowing analysis of soft tissue 
using CT ex vivo [33,34]. Therefore, we hypothesized 
that PTA would also stain the hydrogels, or more 
precisely the remaining covalently cross-linked 
gelatin-LDI scaffolds. Supporting this hypothesis, the 
original implants and, according to progress of 
degradation, their remains could be clearly visualized 
and quantified using CT after PTA staining (Fig. S1c). 
Volumes quantified using the ex vivo PTA-CT method 
were lower than volumes initially measured by MRI 
by a factor of approximately 10. This factor is 
explained by dehydration of hydrogels during the 
staining procedure. However, both quantification 
methods showed strong correlation (r=0.9691, 
P<0.0001) at all time points (Fig. S1d). Taken together, 
the combination of PTA-CT and MRI led to the 
conclusion that our proposed MRI volume analysis 
method is indeed reliable for studying size and 
degradation behavior of implanted gelatin-based 
hydrogels in vivo. 
Hydrogel degradation and tissue interaction in 
vivo 
Successful establishment of the MRI 
quantification method allowed for assessment of the 
volumes of implanted hydrogels over the whole 
degradation period. To this end, and to investigate 
whether a different number of hydrogel implants 
could cause different degradation rates, animals were 
implanted with either G10_LNCO3 or G10_LNCO8 
(unilateral/single implantation, Fig. 2a, Fig. S2a) or 
with both G10_LNCO3 and G10_LNCO8 
(bilateral/double implantation, Fig. 2b, Fig. S2b). 
Corresponding to the hydrolytic degradation profile, 
G10_LNCO8, the hydrogel with the higher degree of 
covalent and physical net points, showed slower 
degradation in vivo in both experimental situations 
compared to G10_LNCO3. After 63 days less than 5% 
of the initial volume of the hydrogel remained in the 
body. In contrast, G10_LNCO3 was almost 
completely (V < 5% of initial volume) degraded after 
35 days. Importantly, a difference in degradation rates 
between animals bearing one implant (single- 
implanted) or two implants (double-implanted) was 
observed. The double-implanted animals showed 
higher initial degradation of G10_LNCO3 and a 
higher degradation of G10_LNCO8 at the later phase 
between day 35 and day 42 after implantation (Fig. 2a, 
2b, Fig. S2c). 
Important mechanisms for degradation of the 
gelatin-based hydrogels are hydrolysis and enzymatic 
degradation [16]. To investigate to which extent 
enzymatic degradation plays a role in vivo, and to 
detect potential differences between the two 
hydrogel-species, MMP activity measurements were 
performed in vivo. In vitro experiments investigating 
the direct contact between endothelial cells (HAEC), 
macrophages (activated THP-1) and the hydrogels 
showed no elevation of MMP levels in the cell culture 
supernatant [16]. However, MMP activity itself was 
not measured in vitro. In vivo, single-implanted 
animals showed material dependent regulation of 
MMP activity over time. In animals single-implanted 
with G10_LNCO3, high MMP activity at 1 and 7 days 
after implantation was observed, followed by a 
continuous decrease of activity levels over time (Fig 
2c). In contrast, MMP activity after unilateral 
implantation of G10_LNCO8 peaked at 14 days after 
implantation, which correlates well with volume 
differences quantified by MRI (Fig. 2a, 2b). 
Double-implanted animals showed an MMP activity 
time course similar to mice single-implanted with 
G10_LNCO3 (Fig. 2d).  





Figure 2. Quantification of hydrogel degradation and local MMP-activity. Degradation behavior of G10_LNCO3 and G10_LNCO8 could be observed noninvasively 
using dedicated small animal MRI with a specialized T2 measuring sequence. Volume was quantified after applying a threshold. Volumes are given as % of initial volume. 
Degradation behavior of G10_LNCO3 and G10_LNCO8 in (a) single-implanted (n=6-7) and (b) double-implanted animals (n=10). In vivo quantification of MMP activity for (c) 
single-implanted and (d) double-implanted animals. Mean + s.d. * G10_LNCO3 vs. G10_LNCO8, # G10_LNCO3 vs. Sham, ° G10_LNCO8 vs. Sham, * p < 0.05, ** p < 0.01. 
 
Additionally, our data show a reciprocal 
influence of implanted hydrogels on each other. This 
was shown for degradation and local MMP activity at 
the implantation site of double-implanted compared 
to single-implanted animals. Due to the observed 
differences between single- and double-implanted 
mice with regard to hydrogel degradation and MMP 
activity, subsequent experiments for determining 
biomaterial-tissue-interaction and systemic response 
of the respective hydrogels ex vivo were carried out 
using only single-implanted animals.  
To further investigate potential inflammatory 
reactions, in vivo optical imaging of double-implanted 
animals using a fluorescent COX-2 inhibitor [35] and a 
reactive oxygen species (ROS) detecting substance 
(L-012) [36,37] were performed. Only minor 
inflammation limited to the incision site on day 1 and 
partly on day 7 after implantation were observed 
when compared to control animals (Fig. S3a, S3b, S3c, 
S3d). Neither elevated COX-2 synthesis nor ROS 
production could be detected at the site of the 
gelatin-based hydrogel.  
To assess whether implantation of G10_LNCO3 
and/or G10_LNCO8 induced proliferation or 
inflammation, two processes detectable by increased 
trapping of [18F]fluorodeoxyglucose ([18F]FDG), 
dynamic small animal PET was performed 14, 21, and 
35 days after implantation. Figure 3a shows 
maximum intensity projections (MIP, 0-60 min, upper 
panel) and transversal PET projections (lower panel, 
30-60 min) co-registered to MRI projections of 
representative mice 14 days after implantation of 
either G10_LNCO3 (left panel) or G10_LNCO8 (mid 
panel) as well as of both G10_LNCO3 and 
G10_LNCO8 (right panel). Single-implanted 
G10_LNCO3 was characterized by only marginal 
[18F]FDG trapping, whereas significant radiotracer 
accumulation could be observed at implantation sites 
of single-implanted G10_LNCO8 and of 
double-implanted animals. Sequential measurements 
of single-implanted mice on day 21 and 35 after 
implantation revealed that in comparison to day 14, 
the mean SUV 30-60 min post injection (p.i.) of 
G10_LNCO3 was similar to mean SUV of muscle 
tissue, which indicates a decreased level of [18F]FDG 
trapping (Fig. 3b, Fig. S4a). This effect was partially 
attributed to degradation of G10_LNCO3. By contrast, 
SUV of G10_LNCO8 first decreased from day 14 to 21, 
but then reached a maximum 35 days after 
implantation. Interestingly, in contrast to 




single-implanted animals, double-implanted mice 
achieved substantial [18F]FDG trapping on day 14 for 
both hydrogels, which is similar to levels at the 
implantation site of single-implanted G10_LNCO8. 
However, despite the similar mean SUVs on day 14 
and 21 for both implants in double-implanted mice, 
no [18F]FDG trapping could be observed on day 35 at 
the implantation site of G10_LNCO3, in contrast to 
G10_LNCO8 (Fig. 3b). Accordance of [18F]FDG PET 
signal and localization of G10_LNCO3 and 
G10_LNCO8 was further confirmed by whole-body 
autoradiography (Fig. 3c). 
 
 
Figure 3. [18F]FDG PET imaging and quantification. (a) Maximum intensity projection, coronal (0-60 min p.i., upper panel) and transversal projection (mid panel, 30-60 
min p.i.) of dynamic PET experiments with [18F]FDG coregistered to MRI projection (lower panel) 14 days after implantation of either G10_LNCO3 (left panel) or G10_LNCO8 
(mid panel) as well as of both G10_LNCO3 and G10_LNCO8 (right panel). (b) Mean SUV of [18F]FDG (30-60 min p.i.) on day 14, 21, and 35 after hydrogel implantation. (c) 
Autoradiography of double-implanted mice 35 days after implantation (the upper panel). Transversal section is shown in the lower panel. Left side shows autoradiography. Whole 
animal cryo-sections are shown on the right side. Mean + s.d. * p < 0.05, ** p < 0.01. 





Figure 4. Histological quantification. Histological quantification of positive-stained area compared to counterstaining of cell nuclei of single-implanted animals. Time course 
for (a) CD68 as pan-macrophage marker, (b) CD206 as M2-macrophage marker, (c) Ki67 for proliferation, (d) S100A4 as fibroblast marker, (e) CD31 as blood vessel marker, and 
(f) VEGFR-2 for new born blood vessels (n=3 different animals). Quantification was applied using color thresholds at mosaic images of whole, centric 10 µm slices of the hydrogel 
implant and the surrounding tissue. Mean + s.d. * G10_LNCO3 vs. G10_LNCO8, # G10_LNCO3 vs. Sham, ° G10_LNCO8 vs. Sham p < 0.1.  
 
Local effects of hydrogel degradation and 
tissue interaction ex vivo 
Specific tissue-hydrogel-interactions on 
microscopic scale were evaluated by 
immunohistochemical studies (Fig. S5a). 
Quantification of the pan-macrophage marker CD68 
revealed a two-peaked accumulation of macrophages 
on day 7 and 21 for G10_LNCO3 and on day 14 and 35 
for G10_LNCO8 (Fig. 4a). Significant differences in 
macrophage accumulation were found between 
G10_LNCO3 and sham-operated mice at the same 
time points and between G10_LNCO8 and 
sham-operated mice on day 14 and 21. CD206, which 
characterizes M2-macrophages (M2Φ), showed 
similar peaks for both materials as observed with 
CD68. The highest amount of M2Φ for G10_LNCO3 
and G10_LNCO8 was observed 21 and 35 days after 
implantation, respectively (Fig. 4b).  
Furthermore, additional cell types associated 
with wound repair and skin regeneration, such as 
keratinocytes and progenitor cells, as indicated by 
staining of involucrin and CD34, accumulated around 
the implanted hydrogels (Fig. S5b, S5c). However, a 
high amount of involucrin- and CD34-positive cells 
was also found around the skin pocket in 
sham-operated animals. Following initial macrophage 
accumulation, fibroblasts play an important role 
during tissue restoration processes [38]. 
Quantification of the fibroblast stem cell marker 
Lrig-1 is shown in Fig. S5d. Only a slightly elevated 
amount of fibroblast stem cells could be observed for 
G10_LNCO3 on day 7 compared to sham-operated 
mice. For G10_LNCO8 a higher amount of Lrig-1 




positive cells compared to sham controls could be 
observed from day 14 onwards. Even though different 
amounts of stem cells were found for G10_LNCO3 
and G10_LNCO8, the proliferative response around 
the hydrogel implants appeared to be of similar 
intensity, as indicated by Ki67-positive cells (Fig. 4c). 
Noticeably, G10_LNCO3 increased proliferation from 
days 14 to 21, compared to a single peak of 
proliferation at day 14 for G10_LNCO8. 
Consequently, a greater amount of S100A4-positive 
fibroblasts at the implant site of G10_LNCO3 was 
found (Fig 4d). The increased amount of fibroblasts 
led to formation of a collagenous capsule around the 
hydrogels (Fig. S5e). The capsule around 
G10_LNCO3 was significantly thinner than the 
capsule around G10_LNCO8. Both materials showed 
the highest capsule thickness 14 days after 
implantation followed by a continuous decrease. On 
day 84 no significant difference in capsule thickness 
between implanted animals and sham controls could 
be detected. A frequently encountered complication 
of current implantation strategies is the fact that 
elevated levels of fibroblasts and collagenous ECM 
lead to ‘irreversible’ fibrotic encapsulation of the 
material, thereby hindering vessel ingrowth and 
supply of newly formed tissue with O2 and nutrients 
[39]. Hence, formation of new blood vessels within the 
implantation site was investigated as well. CD31, a 
well-established endothelial marker, was used to 
identify blood vessels within the tissue. 
Quantification revealed increased CD31 expression at 
the implantation site of G10_LNCO8 compared to 
G10_LNCO3 and sham control on day 21 (Fig. 4e). 
However, using the angiogenesis marker VEGFR-2, 
no significant increase could be detected (Fig. 4f). This 
is due to the high amount of cells found at the implant 
site compared to sham controls, which displayed less 
cells but still showed positively stained areas for 
CD31 and VEGFR-2 as skin is a well-vascularized 
organ. Although quantification showed no significant 
differences, images (Fig. 5a, 5b, Fig. S5a) clearly 
depict a high density of CD31-positive blood vessels 
and VEGFR-2-positive (newly formed) blood vessels 
after implantation of G10_LNCO3 and G10_LNCO8, 
respectively. Already 7 days (G10_LNCO3) and 14 
days (G10_LNCO8) after implantation a ring of 
VEGFR-2-positive newly formed blood vessels was 
observed around both hydrogels (Fig. 5a, 5b). Until 
day 21 the amount of VEGFR-2- and CD31-positive 
cells constantly increased. Blood vessels grew through 
the capsule to reach the tissue-hydrogel-interface, but 
only rarely sprouted into the material itself. 84 days 
after implantation blood vessels receded again and no 
difference in appearance could be observed between 
previously implanted and sham-operated mice.  
Systemic effects of hydrogel degradation and 
tissue interaction ex vivo 
Potential systemic effects of hydrogel 
degradation and tissue interaction were investigated 
by quantifying serum MMP levels and serum 
cytokine levels as well as performing 
pathohistological examinations of inguinal lymph 
nodes, spleen, liver, and kidneys. 
Serum MMP concentrations showed no 
significant elevation compared to sham control mice 
in case of MMP-2 (gelatinase A), MMP-3 
(stromelysin), MMP-8 (neutrophil collagenase), 
proMMP-9 (gelatinase B), and MMP-12 (macrophage 
metalloelastase) (Fig. 6a, 6b, 6c, 6d, 6e). A slightly but 
not significant elevation of MMP-8 in implanted mice 
could be observed 7 days after implantation (Fig. 6c). 
Analysis of serum cytokine levels revealed no effect of 
hydrogel implantation on anti-inflammatory 
cytokines IL-Ra, IL-10, IL-13 as well as on 
pro-inflammatory cytokines IL-1β, IL-6, IFN-γ, and 
TNF-α during degradation of both hydrogels (Fig. 
S6). 
Moreover, pathohistological examination of 
lymphoid organs such as inguinal lymph nodes and 
spleen as well as of liver and kidney, which play a role 
in detoxification and excretion of foreign materials 
and material degradation products, were performed. 
No pathological abnormalities during and after the 
complete degradation of both materials (day 84) 
compared to the sham control mice could be observed 
(Fig. S7). 
Discussion 
This work describes a comprehensive small 
animal imaging study in immunocompetent SKH1 
nude mice in vivo and ex vivo implanted with two 
gelatin hydrogels, stabilized through reaction with 
different amounts of LDI (single- and 
double-implanted or only single-implanted, 
respectively). As major result, this first preclinical 
investigation revealed that both hydrogels resulted in 
complete restoration of the original healthy condition 
(restitutio ad integrum). Despite all necessary caution 
and considering limitations, e.g., of the model, mode 
of implantation, and duration of the study, the results 
strongly suggest the potential for clinical use of 
LDI-stabilized gelatin hydrogels for soft tissue 
regeneration. As second major aspect, this 
investigation established a preclinical, multimodal, 
and multiscale imaging platform suitable for studying 
different hydrogels of interest. 
 





Figure 5. Angiogenesis at the biomaterial-tissue-interface. Representative histological images of angiogenic blood vessels (VEGFR-2) and all blood vessels (CD31) are 
shown at the first and last time point of detection around the hydrogels (a) 7 days (left) and 21 days (right) after implantation for G10_LNCO3 and (b) 14 days (left) and 35 days 
(right) after implantation for G10_LNCO8.  
 





Figure 6. Serum MMP-levels. Time course of (a) MMP-2, (b) MMP-3, (c) MMP-8, (d) proMMP-9, and (e) MMP-12 serum concentrations of single-implanted mice (n=4 different 
animals). Mean + s.d. 
 
Degradation of gelatin-based hydrogels in vivo 
was visualized and quantified using 7 T MRI with 
dedicated T2 sequences. Correct volume 
quantification using MRI was confirmed using an ex 
vivo CT-based method of PTA-stained tissue samples 
[34]. The strong correlation between both datasets at 
all time points further confirmed the high robustness 
of our MRI-based quantification method. Therefore, 
MRI is the method of choice for noninvasive 
investigation of hydrogel degradation in vivo. 
Degradation behavior of G10_LNCO3 and 
G10_LNCO8 clearly revealed that kinetics depend on 
the number of net points. A higher amount of LDI, 
which correlates with an increased number of 
covalent and physical net points, led to an increase in 
degradation time from 35 days for G10_LNCO3 up to 
63 days for G10_LNCO8 until complete (V < 5% of 
initial volume) degradation was achieved. In case of 
the gelatin-based hydrogels tested in this study, 
G10_LNCO3 showed a higher initial degradation, 
whereas G10_LNCO8 was degraded faster at later 
time points. Hydrogels with higher net point density 
likely restrict diffusion of proteases. The later increase 
of degradation rates in these hydrogels may be 
explained by an initial primarily hydrolytic 
degradation, enabling a higher rate of diffusion of 
proteases at later time points, which then accelerate 
the rate of degradation. In vivo MMP activity 
measurements revealed a different time course for 
double-implanted compared to single-implanted 
mice. Implantation of both G10_LNCO3 and 
G10_LNCO8 on a single animal led to an earlier 
activation of MMPs at the implant site. MMP activity 
in general was slightly elevated in double-implanted 
mice. Single-implanted animals showed later 
activation of MMPs at the implant site, especially for 
G10_LNCO8. This suggests that, in response to 
surgery, material, or material degradation products, 
the enzymatic degradation of materials will occur 
more rapidly in double-implanted animals than in 
single-implanted animals. This finding is 
substantiated by the fact that [18F]FDG-PET revealed a 




great difference between single- and 
double-implanted animals. The increased trapping of 
[18F]FDG can serve as an indicator for different 
metabolic states of cells and tissues, such as 
proliferation, inflammation, macrophage 
accumulation, or neovascularization [40,41]. In 
single-implanted animals a great difference in 
[18F]FDG trapping of G10_LNCO3 (low) and 
G10_LNCO8 (high) in the time course of 14 to 35 days 
after implantation was observed. For 
double-implanted mice this difference was 
completely absent for day 14 and 21 after 
implantation. Both implantation sites showed a high 
accumulation of [18F]FDG. This could be due to a 
higher activation of M1Φ around the hydrogels in the 
double-implanted animals, which consequently 
caused higher MMP release and faster initial 
degradation of the lower cross-linked G10_LNCO3 
and a fast degradation of G10_LNCO8 at later time 
points. Single-implanted animals on the other hand 
showed first macrophage accumulation indicated by 
the pan-macrophage staining (likely M1Φ) around 
G10_LNCO3 on day 7 decreasing until day 14 and 
around G10_LNCO8 on day 14 decreasing after day 
35. 
The results suggest that multiple implants per 
animal not only cause systemic effects but also alter 
the local material-tissue interaction, potentially due to 
the greater area of material-tissue interface. This raises 
the question on how reliable data obtained from 
multiple implant animal models are [37,42]. 
Therefore, it is of great importance to use 
single-implanted mice to investigate degradation 
itself and also degradation-specific responses by MRI, 
MMP in vivo measurements, and [18F]FDG-PET 
measurements. Due to the great differences observed 
between single- and double-implanted mice, 
subsequent studies investigating hydrogel tissue 
interaction at microscopic level as well as any 
systemic responses to the implants (MMP levels, 
cytokine levels) were carried out using 
single-implanted mice only.  
Immunohistochemical data revealed no 
difference in the amount of pan- or M1-macrophages, 
however, their temporal regulation was significantly 
different. G10_LNCO3 showed faster accumulation of 
macrophages from day 7 until degradation was 
completed on day 35. For G10_LNCO8, the 
accumulation of macrophages started from day 14 
and lasted until complete degradation on day 84. The 
two peaks in macrophage quantification and 
accordance of the second peak to accumulation of 
M2Φ lead to the conclusion that macrophages act in a 
two-step process during degradation of the two used 
hydrogels. First, M1-like macrophages arrive at the 
biomaterial implant and start degradation via 
secretion of MMPs and other proteases [43]. Next, 
M1Φ switch to M2Φ [44] at the partially degraded 
implant to start tissue regeneration. As proposed by 
van Putten et al. 2013 [45] the classical M1/M2 
differentiation model for macrophages lacks many 
different intermediate types of macrophages. 
Therefore, CD68 pan-macrophage staining could also 
indicate different intermediate states of macrophages, 
which require further characterization by different 
immunochemical co-staining like iNOS for M1Φ [44]. 
During the degradation process, MMPs also play 
an important role in promoting sprouting of new 
blood vessels [46,47] and also gelatin itself has been 
reported to have pro-angiogenic properties [48]. CD31 
and VEGFR-2 immunohistochemistry revealed a 
pro-angiogenic effect of both materials in similar 
intensity only differing in a time-dependent manner. 
Until now, great success in tissue engineering has 
been achieved in the field of ‘medium’ vascularized 
tissues such as skin or cartilage [49,50] compared to 
‘highly’ vascularized organs such as heart or liver. As 
a consequence, bioactive gelatin-based hydrogels, 
which induce angiogenesis, are promising candidates 
for tissue engineering of these ‘highly’ vascularized 
organs [51]. 
Formation of granulation tissue, which normally 
follows the action of macrophages by proliferation of 
fibroblasts [38], was also observed around the 
gelatin-based hydrogels. The amount of proliferation 
and subsequent amount of fibroblasts was slightly 
higher for the lower cross-linked hydrogel. However, 
both hydrogels showed a minor increase of fibroblasts 
compared to sham-operated animals, which lead to 
the conclusion that only a minor amount of collagen 
and granulation tissue was formed. The observed 
elevated capsule thickness does not take cellular and 
collagen density into account. Histological data 
revealed that the capsule showed less dense collagen 
but a high level of newly formed blood vessels, 
indicating a temporary fibrous encapsulation of the 
hydrogel by the organism [52–54], which disappears 
after degradation of the hydrogel without formation 
of scar tissue [48]. 
The hydrogels showed high biocompatibility as 
no systemic effects, such as elevated cytokine or 
serum MMP levels could be detected. Furthermore, 
pathological examination of liver, spleen, kidneys, 
and inguinal lymph nodes revealed no morphological 
changes/necrosis during and after complete 
degradation of implanted materials (day 35 and 84). 
In conclusion, this small animal multimodal 
imaging study presents two novel LDI-cross-linked 
gelatin-based biomaterials to be well tailorable for 
specific degradation rates without causing any 




adverse local tissue reactions or systemic response 
neither in vivo nor ex vivo on a cellular level. 
Both studied materials finally enabled restitutio 
ad integrum in SKH1 immunocompetent nude mice as 
preclinical model. Hydrogel-tissue interactions were 
highly similar for both hydrogels and only showed 
differences in the time required for degradation, 
which was strictly dependent on the excess of LDI in 
comparison to free amine groups during preparation 
of the hydrogels. Additionally, due to the different 
mechanical properties of the hydrogels published in 
former studies [14,16] and the high biocompatibility 
observed in this study, gelatin-based hydrogels offer a 
promising strategy for material-induced tissue 
regeneration in several medical indications. 
Hydrogels with lower Young’s moduli may be 
suitable for skin, mammary, or liver tissue, while 
hydrogels with higher Young’s moduli may enable 
applications in the repair of muscle, cartilage, or 
pre-calcified bone. The hydrogels can be produced 
relatively easy, fast, and cheap, while showing 
superior biocompatibility [4,14,16]. 
Conclusion 
Despite all necessary caution and considering 
study limitations as discussed above, this study 
strongly suggests a potential clinical use of hydrogels 
based on LDI-modified gelatin with different quantity 
of covalent and physical net points in a versatile way, 
e.g., as organ patches or soft tissues replacement 
materials. Moreover, sophisticated multi-modal 
imaging both will impel finding of ‘tailored’ solutions 
for novel hydrogels and, from a translational point of 
view, will essentially contribute to and forecast 
success of treatment. The very early implementation 
of multi-modal imaging approaches in 
biocompatibility testing of novel materials is needed 
to overcome the existing divergence between research 
findings on good in vitro performance but failure in 
translation to clinical application. 
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